°Q½×°Ï>¤ß®®¥ÍÂå
Åý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O
·|­û:²q·Q 10136148 µoªí®É¶¡:2017/8/21 ¤U¤È 05:20:28
§N¼ö´`Àô , ¬O¥|©uªº¥²µM

º¦¶^¥æ´À , ¬OªÑ¥«ªº°¸µM

¶}³o­Óª©¤D¦³·P©ó

Cliff¤j®¦¼w¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡zªº±M·~½×­z

Åý¤p§Ìµo¨¥®É , ²`©È·\¹ï¤j®aªºµ§°O

¤]©È§j½K¤@´ò¬K¤ô , ¯}Ãa¤j®aªY½à±M·~ªº¬ü·P

©Ò¥H , ³o­Óª©

¤£¥u 543 ¥i¥H½Í 1234567890abcdef ¤]Åwªï

§Æ±æ¼ö¾x¬O­ì«h

¥»ª©¬O¦h¨¥°ó ¦h¤è¬Ý¨Æ ¦h±¡¹ï«Ý

¬ß±æ

¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡z¬O§Ú­Ìªº¦@¦Pµ§°O

¡yÅý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O¡z«h¬OÄÝ©ó¤j®aªº¦@¦P¤é°O

´Á«Ý±zªº°Ñ»P

ÁÂÁ¤j®a!

·|­û:kaza10143820µoªí®É¶¡:2018/7/3 ¤W¤È 10:53:34²Ä923½g¦^À³
°w¹ï®ü¥~¤W¥«Ä³ÃD²Ä¤@¦¸µo¨¥

¤pªÑªF®ü¥~¤W¥«·|¦³ºÃ¼{¤]¤£¬O¨S¦³¹D²z

­Ó¤H¥»¨­³o¨â¦~¦Û¨­§ë¸ê´N¦³¨â°_Ãþ¦ü®×¨Ò

1.»··~3307 2.¦í¸sÀç³y¨ÖÁÊ

¨­¬°¤pªÑªF­±¹ï¤jªÑªFªº³g°ý¥u¦³µL©`¦Ó¤w

©Ò¥HÁÙ¬O§Æ±æ½²¸³¤£½×¦³¥ô¦ó·QªkÁÙ¬O¯à­ÝÅU¤pªÑªFÅv¯q

·|­û:rabbit10136567µoªí®É¶¡:2018/7/3 ¤W¤È 10:44:35²Ä922½g¦^À³
Hi

­u®ü¥~¤W¥«¡Aµ²ºâ°Ê§@¤@©w·|¦³¡A¥u¬Oµ²ºâªº¤è¦¡©Î±ø¥ó¦³«Ü¦hºØ¡A

®³µ²ºâªº®×¨Ò¨Ó¼L§ÚÁ¿ªºµ²ºâ¡AÁÙ¯u¤£ª¾¹DÅÞ¿è¬O¬Æ»ò¡A

Á٬ƻòÁÁ¨¥©Î¹DÅ¥¶î»¡¡A¬~½L.....·|¤£·Q¤Ó¦h? XD

Å¥¨ìµ²ºâ¨â­Ó¦r¤§«áÂà´«ªº¸£³U½Ķ­Y¬O ªÑ¼Æ´«²{ª÷¡AºMÂd¡A¨ì¥~°ê¤W¥«¡A¨º§Ú¤]·|¤£²n¡C

¤W­±ªºµ²ºâ¬O³ÌÄꪺ¤è¦¡¡A§Ú¤]¦³ªÑ²¼¡A¤]¤£·|·Q­n³oºØª¬ªp¡C

¦A»¡¤@¦¸¡Aµ²ºâ¦³«Ü¦hºØ¤è¦¡©M®×¨Ò¡A§O¥Î²³æªºª½Æ[¥h½Ķ¡A·PÁ¡C

©Î³\¤§«e¤å³¹¨S§âµ²ºâÁ¿±o§ó¥J²Ó¡AÅý¬Y¨Ç¤H²³æªº»~·|¡A³y¦¨§xÂZ¡A²`·P©êºp¡C

¦Ü©ó²{¹ê¤W§A­Ì´N¤£¬O¤jªÑªF¡Aµ²ºâ¤è¦¡¡A³Ì«á´N¬O 51% ¥H¤WªºªÑ¼Æ¨M©w¡A

§A­Ì­n§â®ü¥~¤W¥«·Q±o«Ü´Î¤]µL§«¡A«Ü¦h¨Æ±¡¦¹¤@®É©¼¤@®É¡A¤£µM·íªì¤ß®®¦b¥xÆW¶Ò¸ê¿³Âd°µÔ£?

³Ì«á¡A²q·Q¤j¡A±Í¤HµL·N»s³y¦¹ª©ªº§xÂZ¡A¦ý¹ï©ó³Q¼v®gªº©_©Ç»¡µü¡A¤£»¡©ú¤]«ÜÃø¹L¡A©êºp¤F¡C

¤]ÁÂÁ§A¤@ª½¥H¨Óªº¸ê°T´£¨Ñ¡A·PÁ¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/7/3 ¤W¤È 09:36:03²Ä921½g¦^À³
¯kµhªvÀø¥«³õ¡G«Dªü¤ùÃþ¤îµhÃĬãµo¼ö«× ±NÄ~ÄòÃz´×

¨Ó·½¡G·s®öÂåÃÄ·s»D ¡@2018-07-02

med.sina.com/article_detail_103_2_48264.html

·í«e¡AÀHµÛ¹ïªü¤ùÃþ¤îµhÃĦ¨Å}©Ê¾á¼~ªº¤é¯q¼W¥[¡A¶V¨Ó¶V¦hªº¤½¥q¥¿¦b­P¤O©ó¶}µo¦³®Ä¦ý¤£¨ã¦³¦¨Å}©ÊªºªvÀøÃĪ«¡C«Dªü¤ùÃþÃĪ«ªºÃöª`«×©M»Ý¨D¤j´T¼W¥[¡C

¤µ¦~¦­¨Ç®É­Ô¡ABCC Researchµo¥¬³ø§i«ü¥X¡AÀHµÛ¯kµhªvÀøªº¤é¯q¦h¾Ç¬ì¤Æ¡B´À¥N©Ê«Dªü¤ùÃþÃĪ«¨Ï¥ÎªºÂX±i¤ÎÂå¥Î¤j³ÂÃĪ«ªº¤é¯q³Q±µ¨ü¡A¥¼¨Ó5¦~¥þ²y«Dªü¤ùÃþÃĪ«ªvÀø¥«³õ¹w­p±N½¤@­¿¡A¦b2022¦~¹F¨ì220»õ¬ü¤¸¡A¦b¹w´ú´Á¡]2018-2022¡^¤ºªº½Æ¦X¦~¼Wªø²v¡]CAGR¡^±N°ª¹F18.0%¡C

BCC Research«ü¥X¡A¦³5¤jÃþ«Dªü¤ùÃþÃĪ«¤è®×¥i¯à·|¨ú¥Nªü¤ùÃþÃĪ«¡A¥]¬A¡GÂå¥Î¤j³ÂÃĪ«¡A­l¥Í©ó»¶´Ô¯ÀªºÃĪ«¡A§tÁ¡²ü¾JªºÃĪ«¡A§t£s-3¯×ªÕ»ÄªºÃĪ«¡A¦×¬r±ìµß¬r¯À¡C¨ä¤¤¡AÂå¥Î¤j³Â¬O¥þ²y³Ì¤jªº²Ó¤À¥«³õ¡A¦û¥þ²y¥«³õ¥÷ÃBªº73%¡A¸Ó²Ó¤À¥«³õ¦b2017¦~³W¼Ò¬°73»õ¬ü¤¸¡A¹w´ú´Á¤ºªºCAGR±N¹F¨ìÅå¤Hªº22.2%¡A2022¦~³W¼Ò¹F¨ì198»õ¬ü¤¸¤§¥¨¡A¦Ó±À°Ê¸Ó²Ó¤À¥«³õµo®iªºÃöÁä¦]¯À´N¬OÂå¥Î¤j³Â±±¨î¯kµhªº¤é¯q±Ä¥Î¡C

®Ú¾Ú¬ü°ê½Ã¥Í©M¤HÃþªA°È³¡¡]HHS¡^ªº¼Æ¾ÚÅã¥Ü¡A¦b¬ü°ê¡A¨C¤Ñ¦³116¤H¦º©óªü¤ùÃþÃĪ«¹L¶q¡C¦b2016¡A¬ü°ê¬ù¦³64000¨ÒÃĪ«¬ÛÃö¦º¤`¡A¨ä¤¤ªü¤ùÃþÃĪ«¬ÛÃö¦º¤`º¦´T³Ì°ª¡C¬ü°ê¯e¯f±±¨î©M¹w¨¾¤¤¤ß¡]CDC¡^µo¥¬ªº¤@¥÷³Ì·s³ø§iÅã¥Ü¡A±q2016¦~7¤ë¦Ü2017¦~9¤ë¡Aªü¤ùÃþÃĪ«¬ÛÃö«æ¶E´N¶E²v¦b¦U¤j¦{¿E¼W30%¡C¥h¦~¡A¨Ó¦ÛEndo»sÃĤ½¥qªº§ïª©ªü¤ùÃþ¤îµhÃÄOpana ER¦]³Q½T»{¥¼¯à¨¾¤îÀݥΡA³Q¬ü°êFDA­n¨DºM¥«¡C

·|­û:Walden10140608µoªí®É¶¡:2018/7/2 ¤U¤È 10:59:51²Ä920½g¦^À³
ÁÁ¨¥¯u®£©Æ

¤@«h´N·Q§â§A­Ì¤â¤¤¦³ªºÄw½Xµ¹»´©ö¬~¥X¨Ó~

·|­û:Amanda10147198µoªí®É¶¡:2018/7/2 ¤U¤È 10:30:28²Ä919½g¦^À³
§Ú¤ä«ù¤ß®®¡AÁöµM³£¤£À´¡A¥i¬OÀ³¸Ó«Ü¦³²L¤O
·|­û:²q·Q10136148µoªí®É¶¡:2018/7/2 ¤U¤È 10:02:45²Ä918½g¦^À³
ÁÂÁÂ

rabbit¤j ´£¥XijÃD Åý»~·|±o¥HÂç²M

§óÁÂÁÂ

¤p³ì¤j

º©¹CªÌ¤j Âç²M³o­Ó¼~¼{ ¸Ñ¶}¤j®aªº¤ßµ²

¤p§Ì¤]§ä¨ì³ß±d¡XKYªº·s»D ´£½Ð°Ñ¦Ò

¡u ³ß±d-KY¹O90%ªÑªFÄ@Äò«ùªÑ­u°ê¥~±¾µP ¬ü´ä¬°­º¿ï ¡v

news.cnyes.com/news/id/4033761

¥Íª«¬Û¦üÃļt³ß±d - KY(6540-TW) ªí¥Ü¡A®Ú¾Ú¤½¥q»PªÑªF³sô«á²Î­p¡A¦³¶W¹L 90% ªºªÑªFÄ@·NÄ~Äò«ù¦³ªÑ²¼¡A¦A¨ì°ê¥~±¾µP¡A¥Ø«eªì¨Bªº®ü¥~±¾µP­pµe¡A±N¬O¥H¬ü°ê¸ò­»´ä¬°¥D­n±¾µP¥«³õ¿ï¶µ¡C

¥t¥~

³¯ÀR¤j «Øijµ²ºâÃöª©

¤p§Ì¥H¬°°Q½×¥i¥HÂç²M»~·| Åý¨Æ¹ê§e²{ À³¦³¨ä¥¿­±¥\¯à

¤ß®®ªÑªF«ùªÑ¬JµM¤£·|³Qµ²ºâ ¥»ª©¤]´NÅý¥¦«ùÄò©M¤ß®®£¸°_¦¨ªø

°ß½Ð¤j®a´£¥XijÃD®É ½Ð¥ý¤©¥H¹LÂo

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a¡I

·|­û:³¯ÀR10141886µoªí®É¶¡:2018/7/2 ¤U¤È 05:56:01²Ä917½g¦^À³
³oºØ¹DÅ¥¶Ã»¡会®`¦º¤ß®®¡B«Øijµ²ºâ関ª©
·|­û:º©¹CªÌ10144096µoªí®É¶¡:2018/7/2 ¤U¤È 05:21:34²Ä916½g¦^À³
rabbit¥S¡A

¥»¨Ó¤£·Q¦A©µÄò³o­Ó¸ÜÃD¡A¦ý¬O¿ù»~ªº¸ê°T¤£¼á²M·|³y¦¨«Ü¦h»~¾É

³Â·Ð¤j®a«áÄò¤£­n¦A¹ï³o­Ó¸ÜÃD¶i¦æ¦^À³°Q½×¡A·P®¦

¡uµ´¹ï¨S¦³¨ì°ê¥~¤W¥««á¡A¤â¤WªÑ²¼·|³Qµ²ºâ³oºØ¨Æ±¡¡v

¤f»¡µL¾Ì¡Aª½±µÁ|¨Ò

1. ©_´º¥ú¹q­uNASDAQ¤W¥«

. 2005/8¡G²×¤î¿³Âd¶R½æ¡AµLµ²ºâ¡A¿³Âd³Ì«á¤@¤Ñ»ù®æ90¥ª¥k

. 2006/3/31¡G¦bNASDAQ IPO¡AªÑªF¥i¥H¥Î·í¤éIPO»ù®æ9¬ü¤¸½æµ¹¨÷°Ó¡A©Î¬Oª½±µ¦b¥«³õ¶R½æ

2. «Ø¥ÃºMÂd¡A´M¨D®ü¥~IPO¡AµLµ²ºâ

3. ³ß±dºMÂd¡AµLµ²ºâ¡A¦ý¬O¦]¬°¬OKY¤½¥qªº½t¬G¡A¤½¥q¥²¶·¦³¶R¦^¾÷¨î¡A¦ý¬OªÑªF¥i¥H¨M©w¬O§_Åý¤½¥q¶R¦^©Î¬OÄ~Äò¸òÀH¤½¥q

·|­û:¤p³ì10135960µoªí®É¶¡:2018/7/2 ¤U¤È 05:11:04²Ä915½g¦^À³
by the way

¥xÆW¥«³õµLªk¦X²z¤ÏÀ³¥«­È,¥h°ê¥~¹ïªÑªF·íµM¬O³Ì¦nªº¿ï¾Ü

¦b¥xÆW¶Ò¸ê¤]µLªk¶Ò¨ì¦X²z»ù®æ

¥t¿³ÂdªÑªF¦b¥xÆWªÑ¥÷¤@¯ë¾Þ§@¬yµ{¬O·|´«¦¨®ü¥~±±ªÑ¤½¥q¦A¨ì®ü¥~Listing

¦b¤U¿³Âd«e§¹¥þ¥i¦Û¥Ñ¶R½æ,¤]¨S¦³Å¥¤£À´ªºµ²ºâ°ÝÃD,¤£·Q¤@°_¥h®ü¥~ªº,§¹¥þ¥i³z¹L¥«³õª½±µ½æ¥X,²³æ©úÁA

·|­û:¤p³ì10135960µoªí®É¶¡:2018/7/2 ¤U¤È 05:03:47²Ä914½g¦^À³
Rabbit ¤j

¿³ÂdªÑ²¼¤£¦üF¤½¥q¤~»Ý©Ó¿Õ¦¬ÁʪѲ¼, ¥»°ê¿³Âd¤½¥q§K,

¤]¨S¦³§AÁ¿¤°»òµ²ºâ°ÝÃD

½Ð°Ñ¦Ò www.selaw.com.tw/LawArticle.aspx?LawID=G0100713

½Ð¬d©ú¦A»¡,¨Ã½Ð§iª¾ªk±ø

·|­û:rabbit10136567µoªí®É¶¡:2018/7/2 ¤U¤È 04:01:43²Ä913½g¦^À³
Hi ¤j®a¦n

¤ß®®¨«¤J°ê»Ú¤Æ¡A¥u¦³¤@­Ó¤è¦V¹ï¤pªÑªF¦³§Q¡A¨º´N¬O¥~¸ê§ë¸ê¡C

­Y¬O¨ì°ê¥~¥h¤W¥«¡A°ò¥»¤W®Ú¾Ú§ÚÃÒ¨÷ªB¤Íªº§iª¾¡A´N¬O¤âÀYªÑ²¼·|³Qµ²ºâ¡A

Áö»¡¿³ÂdªÑ²¼ªºµ²ºâ¡A·|¦³¤½«H¤Oªº·|­pµ²ºâ¡A²z½×¤W ¤£·|¦³·l¥¢¡A¦ý¹ê»Ú©O?

§Ú­Ó¤Hı±o¨º¥i·l¥¢¤j¤F¡C

¯à§ë¸ê¤ß®®¨Ã«ù¦³ªÑ²¼¨â¦~¦h¸ü¡A­nªºµ´¹ï¤£¬O¥h°ê¥~¤W¥«³oºØµ²ªG¡C

¦ýµL½×µ²ªG¦p¦ó¡A¤Ï¥¿§Ú¤]®³¤£¥X100»õ¥X¨Ó§ë¸ê¡A©Ò¥H¤pªÑªF¤]¥u¯à»{©R»{¤À¡A¤j·§¬O³o¼Ë....­ü

¦Ü©ó¬Fªv¤O¤¶¤Jµ¥µ¥¡A¤]§O·Q¤Ó¦h¡A³o¸Ìªº°Q½×¡A¼vÅT¤O¨S¨º»ò¤j....XD

·|­û:²q·Q10136148µoªí®É¶¡:2018/7/2 ¤U¤È 02:42:44²Ä912½g¦^À³
ÄAÂÐ¥D¬yÆ[ÂIªº¬ã¨s

Tau³J¥Õªº¥\¯à ¥i¯à¬OÅý¯«¸g¤¸«O«ù·LºÞ¥Íªø°ÊºA

¨Ó·½¡G¾Ç³N¸g½n ¡@2018-07-02

med.sina.com/article_detail_103_1_48281.html

¦b¥D¬yÆ[ÂI¤¤¡A¬ì¾Ç®a­Ì¬Û«HTau³J¥Õ¯à¦b¸£²Ó­M¤¤°_¨ìí©w·LºÞ¡]¤@ºØ²Ó­M°©¬[¡^ªº§@¥Î¡C¦ýªñ¤éµoªí¦b¡m²Ó­M¡n¥Xª©ªÀºX¤U¡mCurrent Biology¡n¤Wªº¤@¶µ¬ã¨s¡A«h¦³±æÄAÂгo­ÓÆ[ÂI¡CµØ¤H¾ÇªÌLiang Qiang³Õ¤h¦@¦P¥D¾Éªº¤@¶µ¬ã¨sªí©ú¡ATau³J¥Õªº¥\¯à¥i¯à«ê«ê¬Û¤Ï¡X¡X¦b¯«¸g¤¸¨½¡A¥¦ªº¹ê»Ú¥\¯à¬O«O«ù·LºÞ¥Íªø°ÊºA¡A¦Ó¤£¬OÅý¥¦­Ìí©w¡C

¡§¥D¬yÆ[ÂI»{¬°¡A¯«¸g°h¦æ©Ê¯e​​¯fªº±wªÌ¡A¤§©Ò¥H·LºÞ·|¥¢¥h§@¥Î¡A­ì¦]¦b©ó¥¦­ÌÅܱo§ó¤£Ã­©w¡C¦ý§Ú­Ìªº¬ã¨sªí©ú¡A¯Ê¥FTau³J¥Õ«á¡A±wªÌ¯Ê¤Öªº¨ä¹ê¬O·LºÞªº°ÊºA°Ï°ì¡A¡¨¸Ó¬ã¨sªº¦@¦P³q°T§@ªÌPeter Baas³Õ¤h»¡¹D¡G¡§¦]¦¹¡A¦pªG¥Îí©w·LºÞªºÃĪ«¥hªvÀø¯«¸g°h¦æ©Ê¯e​​¯f¡A¥i¯à·|¾A±o¨ä¤Ï¡C¡¨

¦b³o¶µ¬ã¨s¸Ì¡A¬ì¾Ç®a­Ì²M°£¤F¤p¹«¯«¸g¤¸¨½ªºTau³J¥Õ¡AµM«á¤ñ¸û¶b¬ð¤¤ªº·LºÞ¤ô¥­¡C¥L­Ìµo²{¡A¾¨ºÞ¶b¬ð¸Ìªº·LºÞ¶q¦³©Ò¤U­°¡A¦ý³o¨Ã«D¥Ñ©ó¥¦­ÌÅܱo¤£Ã­©w¡C¬Û¤Ï¡A³o¬O¥Ñ©ó·LºÞªº°ÊºA°Ï°ìÅܤ֤F¡C¦Ó¥B¡A·í¯«¸g¤¸¯Ê¥FTau³J¥Õ®É¡A¥¦­Ìªº·LºÞ¹ê»Ú¤W¤Ï¦ÓÅܱo§óí©w¤F¡C³o­Óµo²{¨ê·s¤F§Ú­Ì´X¤Q¦~¨Ó¹ïTau³J¥Õªº»{ª¾¡C

¤U¤@¨B¡A¬ì¾Ç®a­Ì´Á«Ý¦b¨ä¥L°Êª«¼Ò«¬¤¤ÀËÅç¥L­Ìªºµo²{¯à§_±o¨ì­«½Æ¡C¦pªG³o­Óµo²{¨ã¦³´¶¹M©Ê¡A¨º¹ï©óªü¯÷®üÀq¯fµ¥¯«¸g°h¦æ©Êªº¯e¯f¦Ó¨¥¡A¥i¯à±a¨ÓªvÀø¤è®×ªº­²·s¡X¡X¥¦ªí©ú¥Ø«eÁ{§É¸ÕÅ礤¥Î©óí©w·LºÞªºÃĪ«¡A¥i¯à¤£·|°_®Ä¡C

¤£¤[«e¡A§Ú­Ì³ø¾É¤F¯f¬r·P¬V»Pªü¯÷®üÀq¯f¤§¶¡ªº¼ç¦bÁpô¡C¦ÓÃö©óTau³J¥Õªº³o¶µ¬ã¨s¡A¤]¦P¼ËÅý§Ú­Ì­«¼f¹L¥hªº»{ª¾¬O§_¥¿½T¡C³Ìªñ¡Aªü¯÷®üÀq¯f¬ãµo»â°ì¨ú±o¤F¤@¨t¦C®À§é¡C¤£¯}¤£¥ß¡A¤]³\¡A§Ú­Ì¬O®É­Ô¦^¨ì¹êÅç«Ç¡A§ó²`¤J¦a¥h¤F¸Ñ³oºØ¯e¯f¤F¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/7/2 ¤U¤È 02:32:11²Ä911½g¦^À³
¬ü°êFDA²Ä¤G©u«×§å­ãªº·sÃĽLÂI

¨Ó·½¡GÃÄ©ú±d¼w¡@2018-07-02

med.sina.com/article_detail_103_2_48265.html

¤¤¼Ï¯«¸g¨t²Î¯e¯f

ÃĪ«¦WºÙ¡GAimovig¡]erenumab-aooe¡^

¬ãµo¤½¥q¡G¦w¶i¡]Amgen¡^

¾AÀ³¯g¡G°¾ÀYµh¹w¨¾

§å­ãÃþ«¬¡G­º¦¸§å­ã

¦b3´ÁÁ{§É¸ÕÅç¬ã¨sªº³Ì«á¥|©P¡]²Ä9-12¶g¡^¡A¨C¤ë°¾ÀYµh¤Ñ¼Æ¤ñ°ò½u¦Ü¤Ö´î¤Ö50%ªº±wªÌ¤ñ¨Ò¹F¨ì¤F¥D­n²×ÂI¡C­È±o¤@´£ªº¬O¡AAimovig¬OFDA§å­ãªº²Ä¤@­Ó¹w¨¾©Ê°¾ÀYµhªvÀøÃĪ«¡C

ÃĪ«¦WºÙ¡GGilenya¡]fingolimod¡^

¬ãµo¤½¥q¡G¿ÕµØ¡]Novartis¡^

¾AÀ³¯g¡G¦hµo©Êµw¤Æ¯g

§å­ãÃþ«¬¡GÂX¤j¾AÀ³¯g

Á{§É¸ÕÅç¬ã¨sµ²ªGªí©ú¡A¦bªvÀøªº¨â¦~«á¡AGilenya²Õªº¨àµ£±wªÌ¦³86%¨S¦³¥X²{¯gª¬´_µo¡A³o¤@¼Æ¦r¦b¹ï·Ó²Õ¤¤¶È¬°46%¡C°ò©ó³o¤@¥X¦âªº¦¨ªG¡A³o´Ú·sÃĦb·s¾AÀ³¯gªºªvÀø¤W´¿Àò¬ð¯}©ÊÀøªk»{©w©MÀu¥ý¼fµû¸ê®æ¡C³o¬O¬ü°êFDA§å­ãªº­º´Ú¨àµ£¦hµo©Êµw¤Æ¯g·sÃÄ¡C

ÃĪ«¦WºÙ¡GBRIVIACT®¡]brivaracetam, ¥¬¤O¦è©Z¡^

¬ãµo¤½¥q¡GUCB

¾AÀ³¯g¡GÅöíw

§å­ãÃþ«¬¡GÂX¤j¾AÀ³¯g

¬ü°êFDA¤w¸g§å­ã¤F¸Ó¤½¥q³Ì·sªº§ÜÅöíwÃĪ«BRIVIACT®¡]brivaracetam¡A¥¬¤O¦è©Z¡^¤fªA»s¾¯ªº¸É¥R·sÃĥӽС]sNDA)¡A¥Î©ó³æ¿W©Î»²§UªvÀø4·³¤Î¥H¤W±wªÌªº§½³¡Åöíwµo§@¡]partial-onset seizure¡APOS¡^¡C¦¹«e¡AFDA´¿§å­ãBRIVIACT®¥Î©ó³æ¿W©Î»²§UªvÀø16·³¤Î¥H¤W±wªÌªºPOS¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/7/1 ¤U¤È 04:19:30²Ä910½g¦^À³
ÁÂÁÂ

¤Í¤Í¤j

¤p©¯¹B¤j

®ÇÆ[ªÌ¤j

jm0423 ¤j ªº¤À¨É¹ªÀy

¤×¨ä ¤Í¤Í¤j ¥H¨äÂå¾Ç±M·~Æ[ÂI¤À¨É¤ß±o Åý§Ú­Ì§ó¶}ÂX²´¬É ·PÁ±z!

¨â«h·s®öºôªº·s»D

FDA§å­ãNuplazid½¦Ån¾¯©M10mg¤ù¾¯¤W¥« ªvÀø¤Ûı©M¦k·Q

¨Ó·½¡G ¥Íª«¨¦ ¡@2018-07-01

med.sina.com/article_detail_100_1_48242.html

¬ü°ê¥Íª«»sÃĤ½¥qAcadia Pharmaceuticalsªñ¤é«Å¥¬¡A¬ü°êFDA¤w§å­ã¤F©¬ª÷´ËÃĪ«Nuplazid¡]pimavanserin¡^ªº¤@ºØ·sªº½¦Ån¾¯«¬¡]34mg¡^©M¤@ºØ·sªº¤ù¾¯¾¯¶q¡]10mg¡^¡A¥Î©óÀ°§U±wªÌªvÀø©¬ª÷´Ë¯f¡]PD¡^¬ÛÃöªº¤Ûı©M¦k·Qµ¥ºë¯«¯gª¬¡C34mg Nuplazid½¦Ån¾¯©M10mg¤ù¾¯±N©ó8¤ë¤¤¦¯¦b¬ü°ê¤W¥«

¦b¬ü°ê¡ANuplazid©ó2016¦~5¤ëÀòFDA§å­ã¤W¥«¡A¦¨¬°­º­ÓÀò§åªvÀøPD±wªÌ©Ò¸g¾ú¤Ûı©M¦k·Qµ¥ºë¯«¯gª¬ªºÃĪ«¡CNuplazidªºÀò§å¡A¼Ð»xµÛ©¬ª÷´Ë¯f©Êºë¯«¯fÁ{§ÉªvÀøªº­«¤j¨½µ{¸O¡C¤§«e¡AFDA¤w©ó2014¦~±Â¤©Nuplazid¬ð¯}©ÊÃĪ«¸ê®æ¡C

¦bÁ{§É¬ã¨s¤¤¡A»P¦w¼¢¾¯¬Û¤ñ¡ANuplazidÅãµÛ­°§C¤Fºë¯«¯f¯gª¬ªºµo¯fÀW²v©MÄY­«µ{«×¡A¦P®É¥¼·l®`¹B°Ê¥\¯à¡C·~¬É¹ïNuplazidªº°Ó·~«e´º¤]¤Q¤À¬Ý¦n¡AEvaluate Pharma¹w­p¸ÓÃĦb2020¦~ªº¾P°âÃB±N¹F¨ì8.41»õ¬ü¤¸¡A¥t¦³¤ÀªR®v¹w­pNuplazid±N¦b5¦~¤º¦¨¬°¦~¾P10»õ¬ü¤¸ªº­«½SÃĪ«¡C

¤T®a¥Íª«¥ø·~­u´ä¤W¥« ´ä¥æ©Ò­P¤O¥´³y¥Íª«¬ì§Þ¥D­n¸ê¥»¥«³õ

¨Ó·½¡G°·±d¬É ¡@2018-07-01

§@ªÌ¡G¶qÄ_

med.sina.com/article_detail_100_2_48224.html

¤è¹FÂåÃĬO¼Æ¤é¤º­u´ä¤W¥«ªº²Ä¤T®a¥Íª«¥ø·~¡C6¤ë28¤é¡AÄ~·ù¬ìÂåÃÄ¥¿¦¡¦V´ä¥æ©Ò´£¥æ¤W¥«¥Ó½Ð¤§«á¡A¦¹«e´¿¶Ç¥X±ó¬ü­u´ä¤W¥«ªº¸~½FÃĪ«¬ãµo¥ø·~«H¹F¥Íª«¤]¥¿¦¡«Å¥¬¤F­u´ä¤W¥«®ø®§¡C

³o¤T®a¤½¥q³£ÄÝ©ó¥Íª«ÃÄ¥ø¡A­P¤O©ó·sÃĬãµoªº·ù¬ìÂåÃÄ©M«H¹F¥Íª«¨ÃµL°Ó«~¤Æ¥ô¦ó²£«~¡A¦]¦¹¨S¦³¥ô¦ó¦¬¯q¡C

´ä¥æ©ÒªºÁ|±¹¬°¥»¤w¸g¼ö¤õªº¥Íª«ÂåÃĦæ·~¼W²K¤F¼ö«×¡C¥­¦w³Ð§ë¸³¨ÆÁ`¸g²z±i¦¿ªí¥Ü¡A©úÅã·Pı¨ì¥Íª«¬ì§ÞÀY³¡¤½¥q¦ô­È¤ôº¦²î°ª¡A¡§¤µ¦~¥X²{¤F¦h­Ó¦ô­È30»õ¬ü¤¸¥H¤Wªº¤½¥q¡A¤£ºÞA½üÁÙ¬OB½ü¡A³£»¡¦Û¤v¬OPre-IPO½ü¡C¡¨

¾Ú°·±d¬É²Î­p¡A¥Ø«e¤w¸g­u´ä¤W¥«ªº¥Íª«¥ø·~¦³ºq§ÃÄ·~¡B¦¨¤j¥Íª«¡BµØ»âÂåÃĵ¥¡C¤µ¦~¥i¯à­u´ä¤W¥«ªº¥Íª«¬ì§Þ¥ø·~ÁÙ¦³´_§»º~ÀM¡B¤W®ü¤Ñ¤h¤OÃÄ·~¡B¥Ã®õ¥Íª«¡B·LÂ嶰¹Î¡B°·¯à¶©¡B«eªu¥Íª«¡B¶}©ÝÃÄ·~¡B¿Õº¸±dµ¥¡C

·|­û:®ÇÆ[ªÌ10141545µoªí®É¶¡:2018/6/30 ¤U¤È 09:50:30²Ä909½g¦^À³
­Ó¤H·Qªk

¥Í§Þ·sÃĤ½¥q¦³§V¤OªÑ»ù¦Û·|ªíºA..­@¤ßµ¥

²£«~¦³µ²ªG¯àÀò§Q¤~¬O¯u¹ê¤O...¥~¦b®ø®§

³£¬O°²¶H..¤@¯ëªù¥~º~¤Ö¤JÀ¸¤Ó²`¨ü¶Ë¸û¤p

·í¯¸¤W¦~½u·Q¹³¬O¤½¥q§V¤O¥X½u¾÷·|¨ÓÁ{

´²¤á¦ÊªÑ°Ñ»P¤]¥i¼Ö¦b¨ä¤¤

ºë¯«¯fÃĬO²{¥NªÀ·|»Ý¨D²£«~¡A´Á«Ý¤½¥q§V¤O¡A¤Ï«äÃĪ«¥i½w¸Ñ¡A¤£¬O¯u¸ÑÃÄ.

·|­û:¤p©¯¹B10141538µoªí®É¶¡:2018/6/29 ¤U¤È 12:34:42²Ä908½g¦^À³
¤Í¤Í¤j~~

³o¬O¦³¥h°Ñ¥[ªÑªF·|ªººÖ§Q...©Ô¦^¥¿¦n¥[½X¶R...¸`¬Ù¤F«Ü¦h¦¨¥»...

©M©¾¹ê¤á¤Î¤jªÑªF¯¸¦b¦P¤@Ãä´N¹ï¤F...

µ¥«Ý¥¼¨Ó¯¸¤W°ê»Ú...¤ñ»ùSAGE...¥¼¨Ó·sÃij°Äò¬ãµo§¹¦¨...¥«­È·|¶W¶VSAGE...

¥H¤W~~¨Ñµ½¨}.´¼¼zªºªø´Á§ë¸ê¾Ô¤Í­Ì°Ñ¦Ò~~

·|­û:¤Í¤Í10147186µoªí®É¶¡:2018/6/29 ¤W¤È 11:36:29²Ä907½g¦^À³
´X¦~«e¡A¤£¤p¤ß¦b¬Y½×¾Âµo²{¤F¤ß®®¡]·í®ÉÁÙ¥¼¤W¿³Âd¡^¡A·í®É·j¤F¦n¦h¤åÄm¡A°ê¤º³X°Ýªº¡A°ê¥~µoªíªº.......¡A¯u¥¿¤F¸Ñ¤F½²±Ð±Âªº¬ã¨s«á¡]¤F¸Ñ«á¡AÅ嬰¤Ñ¤H¡A³oÃĦpªG¦¨¥\¡A¨ºÁÙ±o¤F¡^¡A«K¶}©l¤F¦¬¶°¤ß®®ªÑ²¼¤§®È¡A§Ú³Ì°ª¦³216¡A³Ì§C¬O50¡A¨â¦~¦h¨Ó¦@¶°¤F100±i¥ª¥k¡A¤@±i³£¨S½æ....¡A

³o´X¤Ñ¬Ý¨ì¤F¤j®aªº¤£¦w¡A§Ú·Q§i¶D¤j®a¡A³o¶¡¤½¥q¡A³o´XÁû·sÃÄ¡A¹ï©ó¥þ²yªº¤H­Ì¡A¯uªº«D±`«D±`ªº­«­n¡A§Ú¦bÁ{§É¤W©Ò¹J¨ìªº±wªÌ¡A´N¬O¦bµ¥«ÝµÛ³o¨ÇÃĪº°Ý¥@¡A¤ß®®¤@©w·|¦¨¥\ªº¡A¦Ü¤Ö¥Ø«e§Úªº¤F¸Ñ¬O¶¶§Qªº¡A§Ú­Ì¯à°µªº¥u¬O¶RªÑ²¼¤ä«ù¡A¤j®a¤@°_¬°¤ß®®¥[ªo³á¡I

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/28 ¤U¤È 10:38:11²Ä906½g¦^À³
¥P¤¦

³¥¤ß

¦Û±þ·N©À

¯«¸g¦A¥Í

Åý¤H¦L¶H²`¨èªº»yµü

·|­û:¦ÌÄ_10132489µoªí®É¶¡:2018/6/28 ¤U¤È 10:14:57²Ä905½g¦^À³
·PÁ¦U¦ì°Ñ¥[ªÑªF·|¤j¤jªº¤À¨É À°§U«Ü¤j

·Q¦b½Ð±Ð¤@¤UªÑªF·|¤¤¦³µL´£¨ì¥Ø«e SND-13¦¬®×ªºª¬ªp?´Á¤¤¤ÀªR°µ¤F¶Ü(©Î¬O¹w­p¦ó®É¶i¦æ?)

Á{§É¹êÅç¤H¼Æ¦³µL½Õ¾ã?¤Î¦b«áÄòªºOPEN TRAIL¦³µL¬Ý¨ì¬Æ»òÁͶÕ?

·P®¦

·|­û:kaza10143820µoªí®É¶¡:2018/6/28 ¤U¤È 10:14:45²Ä904½g¦^À³
¤µ¤Ñ¨Sªk°Ñ»PªÑªF·|

½Ð°Ý¦³°Ñ¥[ªº¥ý¶i

¬O§_¦³½Í¤ÎSND-13¦¬®×¶i«×¡H

¤SSNG-12¬O§_·|¥Ó½ÐBTD?

¥t¥~¦Ñ¥v¤j³o¤S¬O«ç»ò¦^¨Æ¡H

Àµ½Ð¨}µ½®®¤Í¼·¤¾¦^ÂÐ

·|­û:seniorbbs10144999µoªí®É¶¡:2018/6/28 ¤U¤È 08:52:12²Ä903½g¦^À³
¦Ñ¥v¤£¦A¬O¦Ñ¥v¡C¡C¡C
·|­û:SeanYang10141436µoªí®É¶¡:2018/6/28 ¤U¤È 08:43:50²Ä902½g¦^À³
¤µ¤éªÑªF·|¹L«á¡A¦¹ª©¦ó¤é¦A¨£¦Ñ¥v¤j¡H

¤@«h¥H¼~¡A¤@«h¥H³ß§r¡I

·|­û:¤p·ç10140606µoªí®É¶¡:2018/6/28 ¤U¤È 04:57:34²Ä901½g¦^À³
½²¸³¤µ¤ÑÁ¿¤F³\¦h¡A

¤½¥qªº¦U¶µ²£«~¤´«ö³¡´N¯Zªº«e¶i¡A

¼W¸êªº³W¹º¬O¦UºØ¤è®×³£¦³¦Ò¼{¡A®ü¥~©Î°ê¤º³£¬O¿ï¶µ¡A¦~©³§Y¥i´¦¾å¡A

¤ß®®¨ÌµMí¨B«e¶i¡A¤j®a¥i¥H©ñ¤ß~

·|­û:Yendis10145808µoªí®É¶¡:2018/6/28 ¤U¤È 03:24:46²Ä900½g¦^À³
®ü¥~IPO+1 ¤£ª¾¹D¬O¬ü°êÁÙ¬O­»´ä´N¬O¤F
·|­û:·Q·Q10140340µoªí®É¶¡:2018/6/28 ¤U¤È 03:14:38²Ä899½g¦^À³
¦³¤H¹ê¦b·Q­n¥X, ³sµ¥µÛÅ¥ªÑªF·|¤£·QÅ¥...

YEAH! ¦³®ü¥~IPO!!!

·|­û:¤p³ì10135960µoªí®É¶¡:2018/6/28 ¤U¤È 03:04:14²Ä898½g¦^À³
OLD¤j

1.ªÑªF·|ÁÙ¨S¶}´N±þ ,¤À©ú¬O¦³¤H·Q¤U¨®,¤£¥Î§ä²z¥Ñ,¸òªÑªF·|µLÃö

2.¦~©³«e·|¥[¶}ªÑªFÁ{®É·|,°Q½×®ü¥~IPO/¶Ò¸ê¬ÛÃöij®×

3.»¡©ú¦UPipeline¶i«×,±Ð±Â¨ÌµM«H¤ß¤Q¨¬

¥H¤W¨Ñ¤j®a°Ñ¦Ò

·|­û:old10142370µoªí®É¶¡:2018/6/28 ¤U¤È 02:54:02²Ä897½g¦^À³
¤p³ì¤j

¦]¤£§J°Ñ¥[ªÑªF·|

¥i§_¹ï¤µ¤ÑªÑªF²³æ±Ô­z¤@¤U

ÁÂÁÂ

·|­û:¤p³ì10135960µoªí®É¶¡:2018/6/28 ¤U¤È 02:39:24²Ä896½g¦^À³
¤º¦æªºÀ³¸Óª¾¹DªÑªF·|»¡ªº«Ü´Î

­n¤U¨®ªº§Ö¤U¨®§a

·|­û:Benjamin10139027µoªí®É¶¡:2018/6/28 ¤U¤È 01:02:25²Ä895½g¦^À³
¦³­þ¦ì¤j¤j¥i¥H¹ï¤µ¤ÑªºªÑªF·|»¡©ú¤@¤U¡H·P¿E¤£ºÉ
·|­û:seniorbbs10144999µoªí®É¶¡:2018/6/28 ¤U¤È 12:39:15²Ä894½g¦^À³
¥¢±æ©Ê½æÀ£¡C¡C¡C¡C¡C
·|­û:¤j¤á¤H®a10140174µoªí®É¶¡:2018/6/28 ¤U¤È 12:08:47²Ä893½g¦^À³
ªÑªF·|»¡ªº¤£¦n¶Ü?
·|­û:µLµß®ñ10021927µoªí®É¶¡:2018/6/28 ¤U¤È 12:07:35²Ä892½g¦^À³
¤µ¤Ñ³o¤ä¬Oµo¥Í¤°»ò¨Æ¤F?¦n¹³¦³¤H¤£­p¥N»ù¨g­Ë³f....¥Ø«e¶^14¤¸!
·|­û:²q·Q10136148µoªí®É¶¡:2018/6/27 ¤U¤È 04:14:20²Ä891½g¦^À³
½²±Ð±Â¯uªº¬° SNG-12 ( Synapsine® ) ªº¥«³õ©w¦ì§@¥X°Ï¹j

[ Major depressive disorder with suicidal ideation ]

²³ø P.44

www.bplifescience.com/SyneuRxPresentationApril2018.pdf

§Ú­Ì¥H«e½Í¹L Æ{§í¯g»â°ìªºBTD , ¾AÀ³¯g¦U¦³¤£¦P

esketamine : ( »óµÄµ¹ÃÄ )

Àò BTD ®É¶¡ : 2013/11

¾AÀ³¯g : treatment-resistant depression

esketamine :

Àò BTD ®É¶¡ : 2016/08

¾AÀ³¯g :major depressive disorder with imminent risk for suicide.(ÄY­«§íÆ{¯g¨Ã¦³§Y±Nµo¥Íªº¦Û±þ­·ÀI)

Rapastinel : ( NMDA receptor partial agonist ) ÀR¯ßµ¹ÃÄ

Àò BTD ®É¶¡ : 2016/01

¾AÀ³¯g : Adjunctive Treatment of Major Depressive Disorder (MDD)

SAGE-547 : ( GABA modulator ) ÀR¯ßµ¹ÃÄ

Àò BTD ®É¶¡ : 2016/09

¾AÀ³¯g : ªvÀø²£«á§íÆ{¯g¡]PPD¡^

SAGE-217 : ( GABA modulator ) ¤fªA

Àò BTD ®É¶¡ : 2018/02

¾AÀ³¯g :the treatment of major depressive disorder (MDD)

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/26 ¤U¤È 05:33:06²Ä890½g¦^À³
­º­Ó¤j³Â¯ÀÃĪ«EpidiolexÀò¬ü°êFDA§å­ã

¨Ó·½¡G ¥Íª«¨¦ ¡@2018-06-26

med.sina.com/article_detail_103_1_47987.html

­^°ê»sÃĤ½¥qGW Pharma¬O´Óª«·½©Ê¤j³Â¯ÀªvÀø²£«~¬ãµo»â°ìªº¥þ²y»â¾ÉªÌ¡A­P¤O©ó±q¤j³Â¤¤µo²{¡B¶}µo¡B°Ó·~¤Æ·s«¬ªvÀøÃĪ«¡Cªñ¤é¡A¸Ó¤½¥q«Å¥¬¡A¬ü°êFDA¤w§å­ã¤j³Â¯ÀÃĪ«¡X¡XEpidiolex¡]cannabidiol¡A¤j³Â¤G¾J¡^¤fªA²GÅé»s¾¯¡A¥Î©ó2·³¤Î¥H¤W±wªÌ¡A»²§UªvÀø»PLennox-Gastautºî¦X¼x¡]LGS¡^©MDravetºî¦X¼x¡]DS¡^¬ÛÃöªºÅöíw¡C­È±o¤@´£ªº¬O¡A¦¹¦¸§å­ã¡A¨ÏEpidiolex¦¨¬°­º­Ó°ª¯Â«×¡B´Óª«·½©Ê¤j³Â¤G¾J¡]CBD¡^³B¤èÃĪ«»s¾¯¡A¦P®É¤]¬O­º­Ó·s«¬§ÜÅöíwÃĪ«¡]AED¡^¡C

GW¹w­p¡A±N¦b¥¼¨Ó3­Ó¤ë±NEpidiolex±À¦V¬ü°ê¥«³õ¡C·~¬É¹ïEpidiolexªº°Ó·~«e´º¤]¤Q¤À¬Ý¦n¡A¤µ¦~¦~ªì¡A¬ìºÍ°ß¦wµo¥¬³ø§i¹w´ú¡AEpidiolex¦b2022¦~ªº¾P°âÃB±N¹F¨ì12»õ¬ü¤¸¡C

Epidiolex»²§UªvÀøLGS©MDS¬ÛÃöÅöíwªºÀò§å¡A¬O°ò©ó3­ÓIII´Á¦w¥þ©Ê©M¦³®Ä©Ê¬ã¨sªº¼Æ¾Ú¡A¨C¤@­Ó¬ã¨s³£¹F¨ì¤F¥D­n²×ÂI¡C³o¨Ç¬ã¨s¤¤¡AEpidiolexªº¤@¯ë­@¨ü©Ê¨}¦n¡CEpidiolex NDA¤¤¥]¬A¤j¬ù1500¨Ò±wªÌªº¦w¥þ¼Æ¾Ú¡A¥H¤Î¤j¬ù400¨Ò±wªÌ³sÄòªvÀø1¦~¥H¤Wªº¼Æ¾Ú¡C

Lennox-Gastautºî¦X¼x¡]LGS¡^¡A¬O¤@ºØ»P¦~ÄÖ¦³ÃöªºÁô·½©Ê©Î¯gª¬©Ê¥þ¨­©ÊÅöíwºî¦X¼x¡A§Y¦~Ä֨̿à©ÊÅöíw©Ê¸£¯fªº¤@ºØÃþ«¬¡C¨ä¯SÂI¬°µo¯f¦~ÄÖ¦­¡A¥®¨à®É´Á°_¯f¡Aµo§@§Î¦¡¦h¼Ë¡A´¼¤Oµo¨|¨ü¼vÅT¡AªvÀø¸û§xÃø¡C¬O¤@ºØÄY­«ªºÅöíwÃþ«¬¡C

Dravetºî¦X¼x¡]Dravet syndrome¡ADS¡^¤SºÙÀ¦¨àÄY­«¦Ù°}ÅË©ÊÅöíw¡A¬O¤@ºØ¤Ö¨£ªº¥D­n¥Ñ¿ò¶Ç¦]¯À¤Þ°_ªº¶i¦æ©ÊÅöíw©Ê¸£¯f¡A¨ã¦³µo¯f¦~ÄÖ¦­¡Aµo§@Ãþ«¬¦h¼Ë¡Aµo§@ÀW²v°ª¡A´¼¯à·l®`ÄY­«¡AÃĪ«ªvÀø®ÄªG®tµ¥¯SÂI¡C¸Ó¯f¹w«á¸û®t¡A´X¥G©Ò¦³±w¨à³£¦³»{ª¾·l¶Ë¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/22 ¤U¤È 05:03:02²Ä889½g¦^À³
¨Ó¦ÛÀô²y¥Í§Þ³ø¾É ¹ï©ó±wªÌ¤H¼Æªº¸É¥R

Voyager©¬ª÷´Ë¤ó¯g°ò¦]Àøªk ÀòFDA¦A¥ÍÂå¾Ç¥ý¶iÀøªk»{©w¡I

2018/6/22 ¾ã²z/½s¿è³¡

µoªí©ó 2018-06-22 §@ªÌ °OªÌ®}²b

www.gbimonthly.com/2018/06/26799/

¶}µo¯«¸g¯e¯fÀøªkªº¥Íª«Âå¾Ç¤½¥qVoyager Therapeutics¤µ¡]22¡^¤é«Å§G¡A¬ü°êFDA¬°¨äVY-AADC°ò¦]Àøªk¹{¥¬¦A¥ÍÂå¾Ç¥ý¶iÀøªk¡]RMAT¡^»{©w¡A¸Ó»{©w±N¥]¬AFDA§Ö³t³q¹D©M¬ð¯}©ÊÀøªk»{©wªº©Ò¦³Àu¶Õ¡CVY-AADC°ò¦]Àøªk¬°ªvÀøÃø¥H¶i¦æÂå¾ÇºÞ²z¡B¦³ÃĮĪi°Ê¡]motor fluctuations¡^ªº©¬ª÷´Ë¤ó¯g±wªÌ¡C

©¬ª÷´Ë¤ó¯g¬O¤@ºØºC©Ê¯«¸g°h¤Æ©Ê¯e¯f¡A¼vÅT¬ü°ê¬ù100¸U¤H¤f¡A¥þ²y¬ù700-1000¸U¤H¤f¡CÁö¥Ø«e¦h¼Æ©¬ª÷´Ë¤ó¯g±wªÌªº¯f¦]©|¤£²M·¡¡A¦ý¸Ó¯e¯fªº¹B°Ê¯gª¬¬O¥Ñ©ó²£¥Í¯«¸g¶Ç»¼ª«½è¦h¤ÚÓiªº¤¤¸£¯«¸g¤¸¯Ê¥¢©Ò¤Þ°_ªº¡C¥Ø«eÁÙ¨S¦³¯à¦³®Ä´î½w©Î°fÂ੬ª÷´Ë¤ó¯g¶i®iªºÀøªk¡A¥ª±Û¦h¤Ú¤´¬O¸Ó¯e¯fªº¼Ð·ÇªvÀø¤èªk¡C

¨ä¤¤¡A¾Ú¦ô­p¡A°ª¹F15%ªº©¬ª÷´Ë¤ó¯g±wªÌ¨ã¦³Ãøªv©ÊÃĮĪi°Ê¡A¥ª±Û¦h¤Ú¤]µLªk¦³®Ä±±¨î¡CÃĮĪi°Ê«ü±wªÌ¹ïªvÀøªº¤ÏÀ³ÅÜ®t¡A¸g¾ú¸ûªø®É¶¡ªº¹B°Ê½wºC©M»øµw¡A¥ÎÃĤ]µLªk¹F¨ì³Ì¨Î®ÄªG¡A¦¹¤@®É´ÁºÙ¬°¡uÃö³¬´Á¡]OFF-time¡^¡v¡CÃĪ«°_®Äªº®É¶¡¡A¤]´N¬O¡u¶}û£´Á¡]ON-time¡^¡v¤]Åܵu¡C¬°³oÃþ±wªÌ´£¨Ñ¦³®Äªº¯e¯f½w¸Ñ¡A¦¨¬°ÂåÃÄ»â°ì«E«Ý¸Ñ¨MªºÃøÃD¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/22 ¤U¤È 04:53:30²Ä888½g¦^À³
Voyager ©¬ª÷´Ë¯f°ò¦]Àøªk ÀòFDA¦A¥ÍÂå¾Ç¥ý¶iÀøªk»{©w

¨Ó·½¡GÃÄ©ú±d¼w¡@2018-06-22

med.sina.com/article_detail_103_2_47829.html

¤µ¤é¡A¶}µoªvÀø¯«¸g¯e¯fªº¥Íª«Âå¾Ç¤½¥qVoyager Therapeutics«Å¥¬¡A¬ü°êFDA¬°VY-AADC°ò¦]Àøªk¹{µo¤F¦A¥ÍÂå¾Ç¥ý¶iÀøªk¡]RMAT¡^»{©w¡AªvÀøÃø¥H¶i¦æÂå¾ÇºÞ²z¡A¦³¹B°Êªi°Êªº©¬ª÷´Ë¯f±wªÌ¡C

¦¹¦¸ªºRMAT»{©w¬O¬ü°êFDA®Ú¾Ú³Ìªñ21¥@¬öªv·Uªk®×¡]21st Century Cures Act¡^¡A¥Î©ó«P¶i©M§å­ã¥]¬A°ò¦]Àøªk¦b¤ºªº¦A¥ÍÂå¾Ç²£«~ªº¥[³t­p¹º¡C¸Ó»{©w¥]¬AFDA§Ö³t³q¹D©M¬ð¯}©ÊÀøªk»{©wªº©Ò¦³Àu¶Õ¡A¨Ï¨ä¯à°÷»P¸Ó¾÷ºc¶i¦æ¦­´Á¥æ¬y¡A°Q½×´À¥N©Î¤¤´Á²×ÂI¡A¤ä«ù¼ç¦bªº¥[³t§å­ã¨Ãº¡¨¬§å­ã«á­n¨D¡CRMAT»{©w¦®¦bªvÀø¡A­×§ï¡A°fÂà©Îªv·UÄY­«©Î¦M¤Î¥Í©Rªº¯e¯f©Î¯gª¬¡Cªì¨BªºÁ{§ÉÃÒ¾Úªí©ú¡A¸ÓÀøªk¦³¥i¯à¸Ñ¨M³oºØ¯e¯f©Î¯f¯gªº¥¼º¡¨¬ÂåÀø»Ý¨D¡C

¡§RMAT»{©w¬O°ò©ó§Ú­ÌVY-AADCªº1b´ÁÁ{§É¼Æ¾Ú¡A¨Ã¥B¥Nªí¤F¦¹¶µ°ò¦]Àøªk§@¬°©¬ª÷´Ë¯f¼ç¦bªvÀø¤è®×ªº¤@­Ó­«­n¨½µ{¸O¡A¡¨ VoyagerªººÊºÞ¨Æ°È©M½è¶q«OÃÒ°ÆÁ`µôRobert Pietrusko³Õ¤h»¡¡G¡§§Ú­Ì´Á±æ³q¹LRMAT»{©w»PºÊºÞ¾÷ºc±K¤Á¦X§@¡A¬°VY-AADCªº¶}µo´£¨Ñ«ü¾É¡A¥]¬A´£¨Ñ«Øij¥H«K¦³®Ä¦a¤ä«ù³o´ÚÃĪ«Àò±o§å­ã¡C¡¨

·|­û:´M³V10132258µoªí®É¶¡:2018/6/22 ¤W¤È 09:28:33²Ä887½g¦^À³
ÁÂÁÂseniorbbs~

¬Ý¨ì¬Y¤jªÑªF«ùªÑ¼Wªñ2000±i~

Ãø©Ç³Ìªñ¶i¥Xªí¬Ý¨ì·í¦a¨é°Ó¤@ª½¶R¶i!

·|­û:seniorbbs10144999µoªí®É¶¡:2018/6/21 ¤U¤È 11:13:00²Ä886½g¦^À³
¦~³ø¤w¸g¤W¶Ç¨ì¤½¶}Æ[´ú¯¸¤F¡A¦U¦ì®®¤Í¥i¥H¥h°Ñ¾\¡C ¥Ø«e¥Rº¡ªº«H¤ß¡C¡C¡C¡C¡C
·|­û:²q·Q10136148µoªí®É¶¡:2018/6/21 ¤U¤È 04:58:24²Ä885½g¦^À³
³o5´Ú¦b¬ã·sÃÄÁ`»ù­È±N¹F470»õ¬ü¤¸

¨Ó·½¡G·s®öÂåÃÄ·s»D ¡@2018-06-21

med.sina.com/article_detail_103_2_47718.html

3. Biogen ªºªüº¸¯ý®üÀq¯g¹v¦V£]¾ý¯»¼Ë´³¶ô­Ô¿ï·sÃÄ Aducanumab ³º»®µM¦b¦C , EvaluatePharmaÁÙ¦ô¨ä²{­È¦b 84»õ¬ü¤¸ ¥ª¥k

ÁöµM¬Û¦ü§@¥Î¾÷¨îªºÃĪ«±µ³s¥¢±Ñ¡A¦ýEvaluatePharma¨Ì»{¬°¡A¦Ê°·ªºªüº¸¯ý®üÀq¯f­Ô¿ïÃĪ«aducanumabªº²{­È¦b 84»õ¬ü¤¸ ¥ª¥k¡A¦P®É¤@¥¹¤½¥q¦b2020¦~ªì¤½§G¶i¦æ¤¤ÃöÁäÁ{§É¸ÕÅ窺µ²ªG³o¤@¼Æ¦rÁÙ±N¤j´T¤W¤É©Î¤U­°¡C

¦b¤@¶µ¬Û¹ï¸û¤pªº¬ã¨s¤¤¡A¬ã¨s¤H­ûª`·N¨ì¨Ï¥ÎaducanumabªvÀø²Õªº±wªÌ¦bÁ{§Éè§b´ú¸Õ¤¤ªºªí²{¤U­°¸û¤Ö¡A¾¨ºÞ³o¨Ç®t²§¤£¨¬¥H³Q»{¬°¨ã¦³²Î­p¾Ç·N¸q¡C¶È¦b¬ü°ê¡AÁÙ¨S¦³¥ô¦ó¤èªk¥i¥H´î½w³oºØ¼vÅT570¸U¤H¯e¯fªº¶i®i¡C¦pªG¦Ê°·ªº­Ô¿ïÃĪ«¯à°÷¦b§ó¤jªº¸ÕÅ礤±o¨ìÃÒ©ú¡A±N¥i¯à¦¨¬°§óºZ¾PªºÃĪ«¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/21 ¤W¤È 05:48:23²Ä884½g¦^À³
ÁÂÁÂ

¥xÁÞ¤jªº¹ªÀy

¤Óºò±i¤jªº¤À¨É

¤p§Ì¤]¥u¬OÂà¶K¦bºô¤W§ä¨ìªº¸ê®Æ¡A¶È¬°Á|¤â¤§³Ò¦Ó¤w

§Æ±æ¥xÆWªº¥Í§ÞªÑ³£¯à§ä¨ì¦Û¤vªº©w¦ì©M§Q°ò¡A¦b¥«³õ¦û¦³¤@®u¤§¦a

®É¶¡¾÷¹B¨ì¤F¡A¦ÛµM·|´²µo¦Û¨­À³¦³ªº¹ê¤O©M¥ú±m

¥xÆW¥Í§Þ¥[ªo¡I

ÁÂÁ¤j®a¡I

·|­û:¥xÁÞ10138776µoªí®É¶¡:2018/6/21 ¤W¤È 12:39:58²Ä883½g¦^À³
®¥³ß¤ß®®¬ð¯}¦Ê¤¸Ãö¥d

²q·Q¤j§V¤O¬ã¨s¨D¯uªººë¯«¬O¤j®a¾Ç²ßªº¨å½d¡A´Á¬ß©Ò¦³¥xÆW¥Í§ÞÂåÃĪѤ¤¦³¼ç¤OªºªÑ²¼³£¤@Àɤ@ÀɯàÀò±oÀ³¦³ªº»ù­È¡C

·|­û:¤Óºò±i10135421µoªí®É¶¡:2018/6/20 ¤U¤È 06:08:31²Ä882½g¦^À³

¥xÆW¦Y§Ü¼~Æ{ÃĦѤH¤ñ¨Ò¼W¦Ü12.2%

´«ºâ¬ù40.28¸U¦Ñ¤HªA¥Î ¥@½Ã²Õ´¡]¢å¢Ö¢Ý¡^§ó¦ô­p¡A¼~Æ{¯g¤G¡³¤T¡³¦~±N¦¨¬°¯e¯f­t¾á²Ä¤@¦ì

µØµø·s»D 2018/06/19

news.cts.com.tw/cts/general/201806/201806191928807.html

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/19 ¤U¤È 01:23:44²Ä881½g¦^À³
±M®aÆ[ÂI¡þ¹ï§Üªü¯÷®üÀq¯g ±q¸z­pij

2018-06-19 00:02¸gÀÙ¤é³ø ¤ý©É´@

udn.com/news/story/7485/3205553?from=udn_ch2cate6644sub7485_pulldownmenu

¤µ¦~4¤ë9¤é¡A©¬ª÷´Ë¤ó¯g¡]Parkinson¡¦s Disease¡A²ºÙPD¡^CNN³ø¾É¡A2016¦~¥H¬ð¯}©ÊÀøªk³QFDA®Ö­ã¡A¦¨¬°²Ä¤@­ÓªvÀøPD©Ò¾É­P¤Ûı¯gª¬ªº·sÃÄ-NUPLAZID (pimavanserin)¡A¦b¤W¥«¤£¨ì¥b¦~ªº´Á¶¡¡A³º³y¦¨244¦ì±wªÌ¦º¤`¡A¦º¤`²v°ª¹F10.9%¡C

³o®ø®§Åý¨ä¥À¤½¥qAcadia PharmaceuticalsªºªÑ»ù·í¤é­«³Ð22%¡A³Ì«áFDA¨u¨£ªº¦b¨ä¥é³æ¤W¡A¥[µù¶H¼x¦MÀI©Ê¯Å§O³Ì°ªªº¶Â®Øĵ»y¡]black box warning¡^¡A¨Ã¨M©w¹ïNUPLAZID­«±Ò¦w¥þ¼f¬d¡C

...

ªñ¦~¨Ó¡A¯«¸g°h¤Æ©Ê¯e¯fªºÃĪ«¶}µo¥¢±Ñ¤w¬O±`ºA¡AÃĬɥ¨ÀY¤]¤£·Qª±¤F

­±¹ï±µ³sªº¥¢±Ñ¡A¬ì¾Ç¬É¤]¶}©l±´´M¨ä¥LªºªvÀø¤è¦V¡A¨ä¤¤¸z¹Dµß´N¬O³Ì¨ã§Æ±æªº¤è¦V¤§¤@¡C2013¦~¡A¥[¦{²z¤u¾Ç°|ªºSarkis Mazmanian±Ð±Â¡A­º¦¸©ó¡mCell¡n´Á¥Zµoªí¤F¸z¹Dµß·|¼vÅT¸£³¡¬¡°Ê¡A¨Ã»P¼~Æ{¡B¦Û³¬¯g¡B¤Î¸£¯«¸g¯e¯f¬ÛÃö¡C¬ì¾Ç®aµo²{¡A¸z¹D²Óµß¥iÂǥѤº¤Àªc¤è¦¡»P¤j¸£¥æ¬y¡A±±¨î¸z¹D¦åºÞ¤Î¦å¸£»ÙÂzªº³q³z©Ê¡A¶i¦Ó¥æ´¥X©Ò¿×ªº¡u¸z¸£¶b¡v½u¡]gut-brain axis¡^¡C¦b°Êª«¹êÅ礤ÃÒ¹ê¡AÂǥѸz¹D·L¥ÍºA¯à§ïµ½ªü¯÷®üÀq¯g¡B©¬ª÷´Ë¤ó¯g¡B¦hµo©Êµw¤Æ¯g»Pº¥­á¯gµ¥¦hºØ°h¤Æ©Ê¯«¸g¯e¯f¯fÄp¡C

¯«¸g°h¤Æ©Ê¯e¯f¤w¬O¥þ²y³ÌÃe¤jªº¥¼º¡¨¬¥«³õ¡A²´¤UFDA»PEMA¤]³£ºÉ¤O©ñ¼e¬ÛÃö·sÃĪº­n¨D¡A¦Ó¥ý´Á¬ã¨s§ó¯É¯ÉÃÒ¹ê¥Ñ¡u¸z¸£¶b¡vµÛ¤â¡A¬O°Æ§@¥Î³Ì¤p¡B¥i¦æ©Ê³Ì°ªªº¤è¦¡¡C¤Ñ®É¡B¦a§Q¡B¤H©M¤wµM»ô³Æ¡A¥xÆW¬F©²»P¥ø·~À³¿n·¥¤Á¤J¡A§â´¤¦í¤U¤@¥@¥NÃĪ«°Ó¾÷ªº¦P®É¡A¤]³yºÖ¼s¤j±wªÌ¡C

¡]§@ªÌ¬OÆp¥Û¥Í§Þ§ë¸ê¤ÀªR«Ç¤ÀªR®v¡^

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/18 ¤U¤È 09:06:07²Ä880½g¦^À³
¤ß®®¥ÍÂå³Ð¿ì¤H½²ªG¯þ¡B§d¶®¬Â¤Ò°ü³X°ÝLA¬ì§Þ²Õ

2018-06-12

www.roc-taiwan.org/uslax/post/17668.html

¤ß®®¥ÍÂå³Ð¿ì¤HUCLAÂå¾Ç°|ºë¯«¬ì±Ð±Â½²ªG¯þ¡B«n¥[¤j±Ð±Â§d¶®¬Â¤Ò°ü³X°ÝLA¬ì§Þ²Õ¡A¤¤¤È¥Ñ±i´­®i²Õªø°º³\­Y»ö¯µ®Ñ³­¦P¡A»P¸g¤å³B¦¶¤å²»³BªøÀ\±Ô¥æ´«·N¨£¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/18 ¤W¤È 09:25:52²Ä879½g¦^À³
¥Ñ¸ôºtªºÂ²³ø¸ê®Æ

www.bplifescience.com/SyneuRxPresentationApril2018.pdf ]

P.23

Existing therapies have a mean effect size~=0.3 (total score).

SND-13ªºÁ{§É³]­p ES ¬O¥Î¤ñ²{¦æªvÀø¥­§¡­ÈÁÙ¦nªº >=0.5 ( Power >= 85 % )

¦Ó2aÁ{§ÉªºES ¼Æ¾Ú¬O 1.53

³o¬OÁ{§É¥D«ÈÆ[±ø¥ó¤£¤@ªº¦w¥þ¾l¸Î¶Ü?

½²±Ð±Â§â¦ÒÃD³]­pªº©³½u³£±È¶}¤F ? SND-13 ¤S·|µª±o«ç¼Ë©O ?

ªÑªF·|±N©¡ ¤pªº³Ì·Q½Ð±Ð½²±Ð±Âªº¨Æ

·íµMÂ÷¤£¶}Á{§Éªº¶i®i°ÝÃD ¤×¨ä¬OSND-13

¤£ª¾½²±Ð±Â¬O§_Ä@·N³zÅSresponderªºÁ`¼Æ? ¤Î¨ä¦ûÁ`Åé¤ñ¨Ò¦p¦ó? ¤À¥¬ª¬ªp? ÁÙ¦³open label¶¥¬qªº¦¨®Ä?

¨ÌÁ{§Éºôªº¸ê®Æ , §P§OÅãµÛ»P§_ , ¥Îªº¬Ototal score¤À¥¬ªº¼Æ¾Ú, ¦Ó¤£¬O¬Ý¦³µLresponder¤G¤Àªk¨Ó­pºâ

°Ýresponderªº¤H¼Æ©Î¥i²¤²qÃĮĪº¯à¶q?

¤pªº¤£¤~ , ¦³½Ð¤j®a¿ãÅDµ¹¤©«ü¾É «ü¥¿

ÁÂÁ¤j®a!

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/17 ¤U¤È 03:48:21²Ä878½g¦^À³
½LÂI2018¦~5¤ëºë¯«¤Àµõ¯g·sÃĬãµo¶i®i

¨Ó·½¡GÃÄ©ú±d¼w¡@2018-06-17

med.sina.com/article_detail_103_2_47527.html

ºë¯«¤Àµõ¯g¡]schizophrenia¡^¬O¤@ºØ¥H²§±`ªÀ·|¦æ¬°©M¤£¤F¸Ñ²{¹ê¬°¯S¼xªººë¯«»Ùê¡Cºë¯«¤Àµõ¯g±wªÌ¥i¯à·|¥X²{¤Ûı¡]¤j³¡¤À¬O¤ÛÅ¥¡^¡A¦k·Q¡]±`±`¬O©_²§ªº©Î­¢®`ªº¡^¡A«äºû©M¨¥»y²V¶Ã¡Cºë¯«¤Àµõ¯g±wªÌ¸g±`¦³ÃB¥~ªº¤ß²z°·±d°ÝÃD¡A¦pµJ¼{¡A§íÆ{©ÎÃĪ«¨Ï¥Î»Ùê¡C¯gª¬³q±`³vº¥¥X²{¡A±q«C¬K´Á¶}©l¡A«ùÄò«Üªø®É¶¡¡C

ºë¯«¤Àµõ¯g¤j¬ù¦b¥þ²y½d³ò¤º¼vÅT2400¸U¤H¡C¥@¬É½Ã¥Í²Õ´2000¦~ªº¼Æ¾ÚÅã¥Ü¡Aºë¯«¤Àµõ¯gªº¥þ²y±w¯f²v±µªñ1%¡A¨C10000¤H¤¤¬ù¦³1.5¤Hµo¯f¡C¨k©Êµo¥Í²v¤ñ¤k©Ê°ª1.4­¿¡A¨Ã¥B³q±`¨k©Ê§ó¦­¥X²{¡X¡Xµo¯f°ª®p¦~ÄÖ¨k©Ê¬°25·³¡A¤k©Ê¬°27·³¡C

ºë¯«¤Àµõ¯gªº¥D­nªvÀø¤èªk¬O§Üºë¯«¯fÃĪ«ªvÀø¡A³q±`µ²¦X¤ß²zªvÀø©MªÀ·|¤ä«ù¡C¨ä¤¤¤@½uªvÀø¬O§Üºë¯«¯fÃĪ«¡AÃĪ«¥i¥H¦b7¨ì14¤Ñ¤º´î¤Öºë¯«¯fªº¶§©Ê¯gª¬¡CµM¦Ó¡A§Üºë¯«¯fÃĤ£¯àÅãµÛ§ïµ½³±©Ê¯gª¬©M»{ª¾¥\¯à»Ùê¡C®òÁD¥²§Q¡A¶ø´á¥­¡A§Q°öଡA©M´â´á¥­¬O±`¨£ªººë¯«¤Àµõ¯gÃĪ«¡C

ºI¤î2018¦~5¤ë31¤é¡Aºë¯«¤Àµõ¯g»â°ì¦@¦³108¶µ·sÃÄÁ{§É¸ÕÅç¬ã¨s

ºë¯«¤Àµõ¯g·sÃĪºÁ{§É¸ÕÅç¬ã¨s¶°¤¤¦b¬ü°ê¡A¬ü°ê¦³73¶µ¸ÕÅç

¥þ²y¥D­n¬ã¨sºë¯«¤Àµõ¯g·sÃĪº¤½¥q¬O¡G

Alkermes¡]5¶µ¡^¡A

ACADIA¡]5¶µ¡^¡A

Otsuka¡]4¶µ¡^¡A

Sunovion¡]4¶µ¡^¡A

SyneuRx¡]3¶µ¡^¡A

Lundbeck¡]3¶µ¡^¡A

Boehringer Ingelheim¡] 3¶µ¡^¡A

Takeda¡]2¶µ¡^¡A

Brian Miller¡]2¶µ¡^¡A

Iris Sommer¡]2¶µ¡^¡A

Rovi¡]2¶µ¡^¡A

Sumitomo Dainippon Pharma Co., Ltd.¡]2¶µ¡^¡A

Braeburn¡]2¶µ¡^¡AMarinus ¡]2¶µ¡^¡A

Millennium¡]1¶µ¡^¡A

Roche¡]1¶µ¡^¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/17 ¤W¤È 10:45:43²Ä877½g¦^À³
¦³¤@­Óºô¯¸¥i¥HÀ°§U§Ú­Ì¤F¸Ñ½Ñ¦h²Î­p¶qªºÅܤÆÃö«Y

Understanding Statistical Power and Significance Testing---an interactive visualization

rpsychologist.com/d3/NHST/

Type I and Type II errors, £\, £] , p-values, power and effect sizes ¡V the ritual of null hypothesis significance testing contains many strange concepts.

·í§Ú­Ì§â [ Solve for? ] ©ñ¦b [ n ] (Sample size)

¦Ó§â Power (1-£] ) , Significance level ( £\ = 0.05 ) , Effect size ( Cohen¡¦s d ) °µ¨Ç½Õ¾ãÅܤÆ

§Ú­Ì´N¥i¥H±q¹Ï«¬ªºÅÜ¤Æ ÁÙ¦³¼Ë¥»¼Æ¤j¤pªº¼W´î

±q¦Ó¤F¸Ñ SND-13 ªºÁ{§É²Î­p³]©w

[[

• Phase II/III registrational trial is designed to detect an ES >= 0.5 with 85% power

• A sample size reassessment and adjustment will be performed prior to

enrolling the remaining patients to be able to detect an ES >= 0.2* with 80% power on the entire trial

( * ES=0.2 is the minimally clinical meaningful treatment effect. )

]]

¬O§_«O¦u¤F?

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/14 ¤U¤È 04:58:54²Ä876½g¦^À³

1¡þ3ªA¥Î³B¤èÃÄ¥Á²³ ¬ã¨s¡G®£­P¼~Æ{©Î¦Û±þ

2018¦~06¤ë14¤é ¤¤®É¹q¤l³ø ³¯µÎ¯³

www.chinatimes.com/realtimenews/20180614001009-260408

¬ü°ê³Ì·sÂå¾Ç¬ã¨s«ü¥X¡A¹O¤T¤À¤§¤@¬ü°ê¦¨¦~¤H©ÒªA¥Îªº³B¤èÃÄ«~¡A°Æ§@¥Î¥]¬A¥i¯à¾É­P¼~Æ{¯g¡A©Î¼W¥[¦Û±þ¶É¦V¡C

¡u¬ü°êÂå¾Ç·|´Á¥Z¡v¡]Journal of the American Medical Association¡^12¤é¥Zµn³Ì·sÂå¾Ç¬ã¨s¡A°w¹ï2005¦~¦Ü2014¦~¶¡¡A¥þ¬ü¦U¦a2¸U6000¦W¦¨¦~¤HªºÃĪ«¨Ï¥Î¶i¦æ¤ÀªR¡Aµ²ªGµo²{¬Y¨Ç¶W¹L200ºØ¬ü°ê¥Á²³³Ì±`ªA¥Îªº200ºØ³B¤èÃĪ«¡A¼ç¦b°Æ§@¥Î¥]¬A¾É­P¼~Æ{¯g©Î¦Û±þ¡C

²Î­pµo²{¡A®£¾É­P¼~Æ{¯g¡B¦Û±þ­·ÀIªº³B¤èÃĪ«·í¤¤¡A¥]¬A¤F²üº¸»XÁ×¥¥ÃÄ¡B¤ßŦÃÄ¡B¦åÀ£±±¨îÃÄ¡B²BÂ÷¤lÀ°®ú§í¨î¾¯¡]proton-pump inhibitors¡A²ºÙPPIs¡^¡B¨î»Ä¾¯¡]antacids¡^¡B¤îµh¾¯µ¥¡C¦pªG¦¨¦~¤H¦P®ÉªA¥Î¤TºØ¥H¤W¡A¬ù¦³15%±Nµo²{¦Û¤vªAÃÄ´Á¶¡¥X²{¼~Æ{¯g¡F¥u¦³ªA¥Î¤@ºØ¥H¤WÃĪ«ªº¦¨¦~¤H¸Ì¡A¥u¦³7%ªí¥ÜªAÃÄ´Á¶¡¥X²{¼~Æ{¯g¡AªA¥Î¨âºØ¥H¤WÃĪ«ªÌ«h¦³9%»¡²£¥Í¼~Æ{¯g¡C

(¤¤®É¹q¤l³ø)

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/12 ¤U¤È 07:47:43²Ä875½g¦^À³
ªüº¸¯ý®üÀq¯f¬ãµo¦A¨ü®À , §¨Ó²×¤îLanabecestatÁ{§É3´Á¸ÕÅç

¨Ó·½¡G·s®öÂåÃÄ·s»D ¡@2018-06-12

med.sina.com/article_detail_103_2_47343.html

6¤ë12¤é¡A§¨Ó¤½¥q«Å¥¬¡A¨ä©Mªü´µ§Q±d¤½¥q¥¿¦b°±¤î¤fªA£]¤Àªc酶µõ¸Ñ酶¡]BACE¡^§í»s¾¯LanabecestatªvÀøªüº¸¯ý®üÀq¯fªº¥þ²y3´ÁÁ{§É¸ÕÅç¡C¸Ó¨M©w°ò©ó¿W¥ß¼Æ¾ÚºÊ´ú©e­û·|¡]IDMC¡^ªº«Øij¡A¸Ó©e­û·|±o¥Xªºµ²½×¡G¦­´Áªüº¸¯ý®üÀq¯f¸ÕÅçAMARANTH©M°w¹ï»´«×ªüº¸¯ý®üÀq¯fè§bªº¸ÕÅçDAYBREAK-ALZ³£¤£¥i¯à¹F¨ì¨ä¥D­n²×ÂI¡A¦]¦¹À³¸Ó°±¤î¡C§@¬°³o¤@¨M©wªºµ²ªG¡AAMARANTHÂX®i¸ÕÅç¤]±N°±¤î¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/6/11 ¤U¤È 12:28:12²Ä874½g¦^À³
¹ï¤£°_!

§Ñ¤F¶K¤W³sµ²

med.sina.com/article_detail_103_2_47229.html

§Ú­n¦^À³¥»¸ÜÃD
·|­û:
§@ªÌ:
¬ÛÃöªÑ²¼¤½¥q¦WºÙ:¤ß®®¥ÍÂå
¤º®e:
½Ð¥ýµn¤J­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹
°Q½×°Ï¬ÛÃö³W©w¡G
1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«Øij¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
4.¬°ÁקK®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C

¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178 ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѬÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!